The patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030, predicts Roots Analysis
A steadily increasingdemand for participants in clinical research studies, coupled to thecomplexities associated with patient enrolment, have prompted drug / therapydevelopers to outsource this process to specialty service providers
Roots Analysis is pleased toannounce the publication of its recent study, titled, “PatientRecruitment and Retention ServicesMarker, 2019-2030.”
The report offers acomprehensive study of the current scenario and future potential of the playersproviding patient enrollment and retention services. The study features anin-depth analysis, highlighting the capabilities of the various stakeholders inthis domain. In addition to other elements, the study includes:
§ A detailed assessmentof the current market landscape of companies offering patient recruitment andretention services.
§ An analysis of themost active regions (in terms of patient recruitment activity) engagedin this domain, featuring schematic world map representations that highlightkey hubs across the globe.
§ An insightful 2X2representation of the results of a competitiveness analysis of various serviceproviders highlighting capable players in this domain, based on theirrespective capabilities.
§ Comprehensiveprofiles of patient recruitment and retention service providers (shortlistedon the basis of the number of services).
§ An analysis of thepartnerships that have been established in this domain, in the recent past
§ A review of emergingtrends in the industry to overcome the challenges associated with patientrecruitment and retention
§ A detailed marketforecast, featuring analysis of the current and projected future opportunityacross key market segments (listed below)
§ Therapeutic Area
§ Oncology
§ Infectious Diseases
§ CardiovascularDiseases
§ CNS Disorders
§ Respiratory Disorders
§ Metabolic Disorders
§ Others
§ Steps in PatientRecruitment Process
§ Pre-screening
§ Screening
§ Phase of Development
§ Phase I
§ Phase II
§ Phase III
§ Phase IV
§ Key GeographicalRegion
§ North America
§ Europe
§ Asia-Pacific
§ Rest of the world
Transcripts of interviews held with thefollowing senior level representatives of stakeholder companies
§ Simon Klaasen,Co-founder and Managing Director, Link2Trials
§ Hagit Nof, ChiefOperation Officer and Business Development Officer, nRollmed
§ Paul Ivsin, ManagingDirector, Seeker Health
Keycompanies covered in the report
§ Acurian
§ BBK Worldwide
§ Bright Pharmaceuticals Services
§ ClinEdge
§ CSSi
§ CTM
§ FIDELIS RESEARCH
§ Ignite Data
§ Integrated Clinical Trial Services
§ MMG
§ Pacific Groove
§ Polaris BioPharma Consulting
§ Topstone Research
§ TrialWire
§ Tudor Reilly Health
§ WCCT Global
Formore information please click on the following link:
About Roots Analysis
Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
